Evaluated articles

Optimal COVID-19 quarantine and testing strategies

1. Chad R. Wells
2. Jeffrey P. Townsend
3. Abhishek Pandey
4. Seyed M. Moghadas
5. Gary Krieger
6. Burton Singer
7. Robert H. McDonald
8. Meagan C. Fitzpatrick
9. Alison P. Galvani

Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial

1. Yanjun Zhang
2. Gang Zeng
3. Hongxing Pan
4. Changgui Li
5. Biao Kan
6. Yaling Hu
7. Haiyan Mao
8. Qianqian Xin
9. Kai Chu
10. Weixiao Han
11. Zhen Chen
12. Rong Tang
13. Weidong Yin
14. Xin Chen
15. Xuejie Gong
16. Chuan Qin
17. Yuansheng Hu
18. Xiaoyong Liu
19. Guoliang Cui
20. Congbing Jiang
21. Hengming Zhang
22. Jingxin Li
23. Minnan Yang
24. Xiaojuan Lian
25. Yan Song
26. Jinxing Lu
27. Xiangxi Wang
28. Miao Xu
29. Qiang Gao
30. Fengcai Zhu

Multi-organ impairment in low-risk individuals with long COVID

1. Andrea Dennis
2. Malgorzata Wamil
3. Sandeep Kapur
4. Johann Alberts
5. Andrew D. Badley
6. Gustav Anton Decker
7. Stacey A Rizza
8. Rajarshi Banerjee
9. Amitava Banerjee

COVID-19 Transmission Dynamics and Effectiveness of Public Health Interventions in New York City during the 2020 Spring Pandemic Wave

1. Wan Yang
2. Jaimie Shaff
3. Jeffrey Shaman

Error retrieving metadata for 10.1101/32793914

Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreak

1. Akira Endo
2. Centre for the Mathematical Modelling of Infectious Diseases (CMMID) COVID-19 Working Group
3. Quentin J Leclerc
4. Gwenan M Knight
5. Graham F Medley
6. Katherine E Atkins
7. Sebastian Funk
8. Adam J Kucharski

Safety and immunogenicity of the Ad26.COV2.S COVID-19 vaccine candidate: interim results of a phase 1/2a, double-blind, randomized, placebo-controlled trial

1. Jerald Sadoff
2. Mathieu Le Gars
3. Georgi Shukarev
4. Dirk Heerwegh
5. Carla Truyers
6. Anne Marit de Groot
7. Jeroen Stoop
8. Sarah Tete
9. Wim Van Damme
10. Isabel Leroux-Roels
11. Pieter-Jan Berghmans
12. Murray Kimmel
13. Pierre Van Damme
14. Jan de Hoon
15. Williams Smith
16. Kathryn E. Stephenson
17. Dan H. Barouch
18. Stephen C. De Rosa
19. Kristen W. Cohen
20. M. Juliana McElrath
21. Emmanuel Cormier
22. Gert Scheper
23. Jenny Hendriks
24. Frank Struyf
25. Macaya Douoguih
26. Johan Van Hoof
27. Hanneke Schuitemaker

Survey of peridomestic mammal susceptibility to SARS-CoV-2 infection

1. Angela M. Bosco-Lauth
2. J. Jeffrey Root
3. Stephanie M. Porter
4. Audrey E. Walker
5. Lauren Guilbert
6. Daphne Hawvermale
7. Aimee Pepper
8. Rachel M. Maison
9. Airn E. Hartwig
10. Paul Gordy
11. Helle Bielefeldt-Ohmann
12. Richard A. Bowen

Safety and immunogenicity clinical trial of an inactivated SARS-CoV-2 vaccine, BBV152 (a phase 2, double-blind, randomised controlled trial) and the persistence of immune responses from a phase 1 follow-up report

1. Raches Ella
2. Siddharth Reddy
3. Harsh Jogdand
4. Vamshi Sarangi
5. Brunda Ganneru
6. Sai Prasad
7. Dipankar Das
8. Dugyala Raju
9. Usha Praturi
10. Gajanan Sapkal
11. Pragya Yadav
12. Prabhakar Reddy
13. Savita Verma
14. Chandramani Singh
15. Sagar Vivek Redkar
16. Chandra Sekhar Gillurkar
17. Jitendra Singh Kushwaha
18. Satyajit Mohapatra
19. Amit Bhate
20. Sanjay Rai
21. Samiran Panda
22. Priya Abraham
23. Nivedita Gupta
24. Krishna Ella
25. Balram Bhargava
26. Krishna Mohan Vadrevu

COVID-19 deaths detected in a systematic post-mortem surveillance study in Africa

1. Lawrence Mwananyanda
2. Christopher J. Gill
3. William MacLeod
4. Geoffrey Kwenda
5. Rachel Pieciak
6. Zachariah Mupila
7. Francis Mupeta
8. Leah Forman
9. Luunga Ziko
10. Lauren Etter
11. Donald Thea